Completed
Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber
NCT00430157
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +11 more
- Locations
-
- GSK Investigational Site Vienna, Austria